These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22183212)

  • 1. Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity.
    Romero IL; McCormick A; McEwen KA; Park S; Karrison T; Yamada SD; Pannain S; Lengyel E
    Obstet Gynecol; 2012 Jan; 119(1):61-7. PubMed ID: 22183212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study.
    Wang SB; Lei KJ; Liu JP; Jia YM
    Medicine (Baltimore); 2017 Jul; 96(29):e7605. PubMed ID: 28723808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
    Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin intake is associated with better survival in ovarian cancer: a case-control study.
    Kumar S; Meuter A; Thapa P; Langstraat C; Giri S; Chien J; Rattan R; Cliby W; Shridhar V
    Cancer; 2013 Feb; 119(3):555-62. PubMed ID: 23208739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
    Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
    BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus and ovarian cancer: more complex than just increasing risk.
    Shah MM; Erickson BK; Matin T; McGwin G; Martin JY; Daily LB; Pasko D; Haygood CW; Fauci JM; Leath CA
    Gynecol Oncol; 2014 Nov; 135(2):273-7. PubMed ID: 25220626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?
    Lemon LS; Orr B; Modugno F; Buckanovich RJ; Coffman L; Edwards RP; Taylor S
    Gynecol Oncol; 2022 Apr; 165(1):60-66. PubMed ID: 35140015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
    Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
    Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.
    Bayraktar S; Hernadez-Aya LF; Lei X; Meric-Bernstam F; Litton JK; Hsu L; Hortobagyi GN; Gonzalez-Angulo AM
    Cancer; 2012 Mar; 118(5):1202-11. PubMed ID: 21800293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer.
    Garrett CR; Hassabo HM; Bhadkamkar NA; Wen S; Baladandayuthapani V; Kee BK; Eng C; Hassan MM
    Br J Cancer; 2012 Apr; 106(8):1374-8. PubMed ID: 22421948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.
    Al Omari A; Abdelkhaleq H; Al-Hussaini M; Turfa R; Awad N; Hassan MM; Alfaqih MA; Garrett CR
    J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30084749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Metformin on Survival Outcomes of Non-Metastatic Breast Cancer Patients with Type 2 Diabetes.
    Behrouzi B; Zokaasadi M; Mohagheghi MA; Emami AH; Sadighi S
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):611-616. PubMed ID: 33639681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and survival in diabetic patients with breast cancer.
    El-Benhawy SA; El-Sheredy HG
    J Egypt Public Health Assoc; 2014 Dec; 89(3):148-53. PubMed ID: 25534180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
    Pusceddu S; Vernieri C; Di Maio M; Marconcini R; Spada F; Massironi S; Ibrahim T; Brizzi MP; Campana D; Faggiano A; Giuffrida D; Rinzivillo M; Cingarlini S; Aroldi F; Antonuzzo L; Berardi R; Catena L; De Divitiis C; Ermacora P; Perfetti V; Fontana A; Razzore P; Carnaghi C; Davì MV; Cauchi C; Duro M; Ricci S; Fazio N; Cavalcoli F; Bongiovanni A; La Salvia A; Brighi N; Colao A; Puliafito I; Panzuto F; Ortolani S; Zaniboni A; Di Costanzo F; Torniai M; Bajetta E; Tafuto S; Garattini SK; Femia D; Prinzi N; Concas L; Lo Russo G; Milione M; Giacomelli L; Buzzoni R; Delle Fave G; Mazzaferro V; de Braud F
    Gastroenterology; 2018 Aug; 155(2):479-489.e7. PubMed ID: 29655834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.
    He XX; Tu SM; Lee MH; Yeung SJ
    Ann Oncol; 2011 Dec; 22(12):2640-2645. PubMed ID: 21415239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes.
    Oppong BA; Pharmer LA; Oskar S; Eaton A; Stempel M; Patil S; King TA
    Cancer Med; 2014 Aug; 3(4):1025-34. PubMed ID: 24944108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
    Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of metformin on survival in patients with melanoma-national cohort study.
    Urbonas V; Rutenberge J; Patasius A; Dulskas A; Burokiene N; Smailyte G
    Ann Epidemiol; 2020 Dec; 52():23-25. PubMed ID: 32980534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast Cancer Patients.
    Tharakan S; Zimmerman B; Ru M; Blanter J; Cascetta K; Tiersten A
    Oncology; 2020; 98(8):589-592. PubMed ID: 32182614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.